title: Fas apoptosis inhibitory molecule is upregulated by IGF-1 signaling and modulates Akt activation and IRF4 expression in multiple myeloma.
abstract: Multiple myeloma (MM) is an incurable malignancy of terminally differentiated B-lymphoid cells. Here, we investigate the role of Fas apoptosis inhibitory molecule (FAIM) in MM. We demonstrate that insulin-like growth factor 1 (IGF-1) treatment upregulated FAIM expression in MM cells in a dose-dependent manner. Silencing of FAIM expression attenuates Akt signaling downstream of IGF-1 and compromises the viability of MM cells. We further showed that IGF-1 stimulation of MM cells leads to enhanced expression of IRF4, a known 'addictive' factor for MM. This upregulation of IRF4 expression by IGF-1 treatment of MM cells is abrogated when FAIM expression is silenced or Akt activation is inhibited. Thus, FAIM modulates IGF-1-induced Akt activation and IRF4 expression and has a role in MM cell survival. Consistent with these findings, FAIM expression is shown to be higher in plasma cells of symptomatic MM patients compared with normal individuals or patients with premalignant conditions. Moreover, a higher level of FAIM expression is shown to correlate with poorer survival outcomes of newly diagnosed MM patients treated with stem cell transplantation or relapsed MM patients treated in clinical trials with Bortezomib. Thus taken together, our study reveals a novel, as well as clinically relevant role for FAIM in MM.
authors.affiliation: Immunology Group, Bioprocessing Technology Institute, Agency for Science, Technology and Research (A*STAR), Republic of Singapore.
authors.forename: J
authors.initials: J
authors.lastname: Huo
authors.forename: S
authors.initials: S
authors.lastname: Xu
authors.forename: B
authors.initials: B
authors.lastname: Lin
authors.forename: W-J
authors.initials: WJ
authors.lastname: Chng
authors.forename: K-P
authors.initials: KP
authors.lastname: Lam
mesh_terms: D051017:Apoptosis Regulatory Proteins / Q000502:physiology*; D045744:Cell Line, Tumor; D002470:Cell Survival; D004789:Enzyme Activation; D006801:Humans; D007334:Insulin-Like Growth Factor I / Q000502:physiology*; D050835:Interferon Regulatory Factors / Q000235:genetics*; D009101:Multiple Myeloma / Q000378:metabolism* / Q000401:mortality / Q000473:pathology; D011379:Prognosis; D051057:Proto-Oncogene Proteins c-akt / Q000378:metabolism*; D015398:Signal Transduction; D015854:Up-Regulation; D000099218:Interferon Regulatory Factor-4
chemical_list: D051017:Apoptosis Regulatory Proteins; D007334:Insulin-Like Growth Factor I; D050835:Interferon Regulatory Factors; D051057:Proto-Oncogene Proteins c-akt; D000099218:Interferon Regulatory Factor-4; C421307:FAIM protein, human